Status of sentinel lymph node for breast cancer

Seminars in Nuclear Medicine

Volumn 43, Issue 4, 2013, Pages 281-293

  Moncayo, Valeria M ^a   Aarsvold, John N ^a,b   Grant, Sandra F ^b   Bartley, Scott C ^c   Alazraki, Naomi P ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN TC 99M COLLOID; ANTIMONY TECHNETIUM SULFIDE TC 99M; ISOSULFAN BLUE; TECHNETIUM SULFUR COLLOID TC 99M;

ARTICLE; BREAST CANCER; BREAST RECONSTRUCTION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DOSIMETRY; ECHOGRAPHY; FALSE NEGATIVE RESULT; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MALE BREAST; MALE BREAST CANCER; MORBIDITY; OCCUPATIONAL EXPOSURE; OVERALL SURVIVAL; PATIENT CODING; PATIENT SATISFACTION; PRACTICE GUIDELINE; QUALITY OF LIFE; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RARE DISEASE; REIMBURSEMENT; SENTINEL LYMPH NODE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL RATE;

ANIMALS; BREAST NEOPLASMS; DIAGNOSTIC IMAGING; HUMANS; RADIOACTIVE TRACERS; RADIOPHARMACEUTICALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENTINEL LYMPH NODE BIOPSY;

EID: 84878356854     PISSN: 00012998     EISSN: 15584623     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2013.02.004     Document Type: Article

References (111)

1. L.R. Goldfarb, N.P. Alazraki, and D. Eshima Lymphoscintigraphic identification of sentinel lymph nodes: Clinical evaluation of 0.22-micron filtration of Tc-99m sulfur colloid Radiology 208 2 1998 505 509
2. W.S.I. Halsted The results of radical operations for the cure of carcinoma of the breast Ann Surg 46 1 1907 1 19
3. R.M. Cabanas An approach for the treatment of penile carcinoma Cancer 39 2 1977 456 466
4. D.L. Morton, L. Wanek, and J.A. Nizze Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic Ann Surg 214 4 1991 491 499 [discussion 499-501]
5. J.C. Alex, and D.N. Krag Gamma-probe guided localization of lymph nodes Surg Oncol 2 3 1993 137 143
6. J.J. Albertini, G.H. Lyman, and C. Cox Lymphatic mapping and sentinel node biopsy in the patient with breast cancer J Am Med Assoc 276 22 1996 1818 1822
7. K.M. McMasters, T.M. Tuttle, and D.J. Carlson Sentinel lymph node biopsy for breast cancer: A suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used J Clin Oncol 18 13 2000 2560 2566
8. E. Newman, and L. Newman Lymphatic mapping techniques and sentinel lymph node biopsy in breast cancer Surg Clin North Am 87 2 2007 353
9. American Cancer Society. Breast Cancer Facts & Figures 2012-2013. American Cancer Society, Inc. Atlanta, GA, USA, 2012.
10. T. Ashikaga, D.N. Krag, and S.R. Land Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection J Surg Oncol 102 2 2010 111 118
11. G. Gill Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): A randomized controlled surgical trial Ann Surg Oncol 16 2 2009 266 275
12. R.E. Mansel, L. Fallowfield, and M. Kissin Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial J Natl Cancer Inst 98 9 2006 599 609
13. G. Zavagno, G.L. De Salvo, and G. Scalco A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: Results of the Sentinella/GIVOM trial Ann Surg 247 2 2008 207 213
14. U. Veronesi, G. Paganelli, and G. Viale Sentinel-lymph-node biopsy as a staging procedure in breast cancer: Update of a randomised controlled study Lancet Oncol 7 12 2006 983 990
15. A. Giuliano, L. McCall, and P. Beitsch Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial Ann Surg 252 3 2010 426
16. A.D. Purushotham, S. Upponi, and M.B. Klevesath Morbidity after sentinel lymph node biopsy in primary breast cancer: Results from a randomized controlled trial J Clin Oncol 23 19 2005 4312 4321
17. J.L. Fougo, M. Dinis-Ribeiro, and C. Araujo Impact of lymphadenectomy on axillary recurrence and morbidity of the upper limb in breast cancer patients with negative sentinel node. A prospective randomised study Cir Esp 89 5 2011 307 316
18. G. Canavese, A. Catturich, and C. Vecchio Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: Results of randomized trial Ann Oncol 20 6 2009 1001 1007
19. D.N. Krag, S.J. Anderson, and T.B. Julian Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: Overall survival findings from the NSABP B-32 randomised phase 3 trial Lancet Oncol 11 10 2010 927 933
20. U. Veronesi, G. Viale, and G. Paganelli Sentinel lymph node biopsy in breast cancer: Ten-year results of a randomized controlled study Ann Surg 251 4 2010 595 600
21. S.R. Land, J.A. Kopec, and T.B. Julian Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32 J Clin Oncol 28 25 2010 3929 3936
22. U. Veronesi, G. Paganelli, and G. Viale A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 6 2003 546 553
23. G.H. Lyman, A.E. Giuliano, and M.R. Somerfield American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol 23 30 2005 7703 7720
24. E. Hindie, D. Groheux, and I. Brenot-Rossi The sentinel node procedure in breast cancer: Nuclear medicine as the starting point J Nucl Med 52 3 2011 405 414
25. K.M. McMasters, S.L. Wong, and R.C. Martin 2nd Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: Results of a multiinstitutional study Ann Surg 233 5 2001 676 687
26. A. Mudun, Y. Sanli, and V. Ozmen Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: Single institution experience Clin Nucl Med 33 4 2008 262 267
27. A. Frati, Y. Delpech, and A. Bricou Sentinel lymph node detection in patients with early-stage breast cancer: Which site of injection in 2011? Gynecol Obstet Fertil 39 11 2011 620 623
28. K.M. Lin, T.H. Patel, and A. Ray Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes J Am Coll Surg 199 4 2004 561 566
29. Y. Sanli, K. Berberoglu, and C. Turkmen The value of combined peritumoral and subdermal injection techniques for lymphoscintigraphy in detection of sentinel lymph node in breast cancer Clin Nucl Med 31 11 2006 690 693
30. A.M. Argon, U. Duygun, and E. Acar The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node Clin Nucl Med 31 12 2006 795 800
31. A. Eroglu, A. Mudun, and K. Berberoglu Comparison of subdermal and peritumoral injection techniques of lymphoscintigraphy to determine the sentinel lymph node in breast cancer Clin Nucl Med 29 5 2004 306 311
32. C.B. Johnson, C. Boneti, and S. Korourian Intraoperative injection of subareolar or dermal radioisotope results in predictable identification of sentinel lymph nodes in breast cancer Ann Surg 254 4 2011 612 618
33. J.F. Rodier, M. Velten, and M. Wilt Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial J Clin Oncol 25 24 2007 3664 3669
34. J.N. Aarsvold, and N.P. Alazraki Update on detection of sentinel lymph nodes in patients with breast cancer Semin Nucl Med 35 2 2005 116 128
35. D. Eshima, L.A. Eshima, and N.M. Gotti Technetium-99m-sulfur colloid for lymphoscintigraphy: Effects of preparation parameters J Nucl Med 37 9 1996 1575 1578
36. S.C. Dragotakes, R.J. Callahan, and L.C. LaPointe Particle size characterization of a filtered Tc-99m sulfur colloid preparation for lymphoscintigraphy J Nucl Med 36 1995 80P [abstract]
37. A.J. Wilhelm, G.S. Mijnhout, and E.J. Franssen Radiopharmaceuticals in sentinel lymph-node detection - An overview Eur J Nucl Med 26 4 suppl 1999 S36 S42
38. R.F. Uren, R.B. Howman-Giles, and J.F. Thompson Mammary lymphoscintigraphy in breast cancer J Nucl Med 36 10 1995 1775 1780
39. R.F. Uren, R.B. Howman-Giles, and H.M. Shaw Lymphoscintigraphy in high-risk melanoma of the trunk: Predicting draining node groups, defining lymphatic channels and locating the sentinel node J Nucl Med 34 9 1993 1435 1440
40. Nanocoll [package insert] Brondby D, GE healthcare, 2012. Available at: http://www.produktresume.dk/docushare/dsweb/GetRendition/Document-13422/html. Accessed September, 2012
41. M.M. Edreira, L.L. Colombo, and J.H. Perez In vivo evaluation of three different 99mTc-labelled radiopharmaceuticals for sentinel lymph node identification Nucl Med Commun 22 5 2001 499 504
42. S. Gordon Alternative activation of macrophages Nat Rev Immunol 3 1 2003 23 35
43. A.M. Wallace, C.K. Hoh, and D.D. Darrah Sentinel lymph node mapping of breast cancer via intradermal administration of Lymphoseek Nucl Med Biol 34 7 2007 849 853
44. D.R. Vera, A.M. Wallace, and C.K. Hoh [(99m)Tc]MAG(3)-mannosyl-dextran: A receptor-binding radiopharmaceutical for sentinel node detection Nucl Med Biol 28 5 2001 493 498
45. S. Leong, J. Kim, and M. Ross A phase 2 study of (99m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer Ann Surg Oncol 18 4 2011 961 969
46. A.M. Wallace, C.K. Hoh, and K.K. Limmer Sentinel lymph node accumulation of Lymphoseek and Tc-99m-sulfur colloid using a 2-day protocol Nucl Med Biol 36 6 2009 687 692
47. C.A. Tokin, F.O. Cope, and W.L. Metz The efficacy of tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: A comparative review and meta-analysis of the (99m)Tc-labeled nanocolloid human serum albumin standard of care Clin Exp Metastasis 29 7 2012 681 686
48. R.F. Uren, R. Howman-Giles, and D.K. Chung SPECT/CT scans allow precise anatomical location of sentinel lymph nodes in breast cancer and redefine lymphatic drainage from the breast to the axilla Breast 21 4 2012 480 486
49. I. van der Ploeg, R. Valdes-Olmos, and B. Kroon The hybrid SPECT/CT as an additional lymphatic mapping tool in patients with breast cancer World J Surg 32 9 2008 1930 1934
50. S. Vidal-Sicart, O.R. Brouwer, and R.A. Valdes-Olmos Evaluation of the sentinel lymph node combining SPECT/CT with the planar image and its importance for the surgical act Rev Esp Med Nucl 30 5 2011 331 337 [in Spanish]
51. H. Lerman, U. Metser, and G. Lievshitz Lymphoscintigraphic sentinel node identification in patients with breast cancer: The role of SPECT-CT Eur J Nucl Med Mol Imaging 33 3 2006 329 337
52. H. Lerman, G. Lievshitz, and O. Zak Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer J Nucl Med 48 2 2007 201 206
53. D.B. Husarik, and H.C. Steinert Single-photon emission computed tomography/computed tomography for sentinel node mapping in breast cancer Semin Nucl Med 37 1 2007 29 33
54. A. Quon, and S.S. Gambhir FDG-PET and beyond: Molecular breast cancer imaging J Clin Oncol 23 8 2005 1664 1673
55. B.I. Song, S.W. Lee, and S.Y. Jeong 18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer J Nucl Med 53 9 2012 1337 1344
56. R. Peare, R.T. Staff, and S.D. Heys The use of FDG-PET in assessing axillary lymph node status in breast cancer: A systematic review and meta-analysis of the literature Breast Cancer Res Treat 123 1 2010 281 290
57. L. Evangelista, D. Rubello, and G. Saladini Can FDG PET/CT monitor the response to hormonal therapy in breast cancer patients? Eur J Nucl Med Mol Imaging 39 3 2012 446 449
58. J. Dose Schwarz, M. Bader, and L. Jenicke Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET J Nucl Med 46 7 2005 1144 1150
59. N. Avril, J. Dose, and F. Janicke Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose J Natl Cancer Inst 88 17 1996 1204 1209
60. B.B. Koolen, R.A. Valdes Olmos, and P.H. Elkhuizen Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy Breast Cancer Res Treat 135 1 2012 231 240
61. A. Sever, P. Mills, and J. Weeks Preoperative needle biopsy of sentinel lymph nodes using intradermal microbubbles and contrast-enhanced ultrasound in patients with breast cancer Am J Roentgenol 199 2 2012 465 470
62. J. Bonnema, A.N. van Geel, and B. van Ooijen Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: New diagnostic method World J Surg 21 3 1997 270 274
63. H. Caretta-Weyer, G.A. Sisney, and C. Beckman Impact of axillary ultrasound and core needle biopsy on the utility of intraoperative frozen section analysis and treatment decision making in women with invasive breast cancer Am J Surg 204 3 2012 308 314
64. Clarke RH, BW: Evolution of ICRP Recommendations 1977, 1990, 2007 - Publications 26 to 60 to 103. OECD NEA, No 6920, 2011
65. L. Bergqvist, S.E. Strand, and B. Persson Dosimetry in lymphoscintigraphy of Tc-99m antimony sulfide colloid J Nucl Med 23 8 1982 698 705
66. M. Cremonesi, M. Ferrari, and E. Sacco Radiation protection in radioguided surgery of breast cancer Nucl Med Commun 20 10 1999 919 924
67. W.A. Waddington, M.R. Keshtgar, and I. Taylor Radiation safety of the sentinel lymph node technique in breast cancer Eur J Nucl Med 27 4 2000 377 391
68. M. Law, K.C. Cheng, and P.M. Wu Patient effective dose from sentinel lymph node lymphoscintigraphy in breast cancer: A study using a female humanoid phantom and thermoluminescent dosemeters Br J Radiol 76 911 2003 818 823
69. S. Sata, K. Knesaurek, and B.R. Krynyckyi Effective dose in sentinel lymph node imaging Br J Radiol 77 920 2004 709 [author reply 709]
70. M. Law, L.W. Chow, and A. Kwong Sentinel lymph node technique for breast cancer: Radiation safety issues Semin Oncol 31 3 2004 298 303
71. O. Gentilini, M. Cremonesi, and G. Trifiro Safety of sentinel node biopsy in pregnant patients with breast cancer Ann Oncol 15 9 2004 1348 1351
72. G. Dubernard, J.R. Garbay, and R. Rouzier Safety of sentinel node biopsy in pregnant patients Ann Oncol 16 6 2005 987 [author reply 987-988]
73. N. Pandit-Taskar, L.T. Dauer, and L. Montgomery Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients J Nucl Med 47 7 2006 1202 1208
74. S.L. Stratmann, T.M. McCarty, and J.A. Kuhn Radiation safety with breast sentinel node biopsy Am J Surg 178 6 1999 454 457
75. T.J. Miner, C.D. Shriver, and P.R. Flicek Guidelines for the safe use of radioactive materials during localization and resection of the sentinel lymph node Ann Surg Oncol 6 1 1999 75 82
76. A.Y. de Kanter, P.P. Arends, and A.M. Eggermont Radiation protection for the sentinel node procedure in breast cancer Eur J Surg Oncol 29 4 2003 396 399
77. R. Morton, P.W. Horton, and D.J. Peet Quantitative assessment of the radiation hazards and risks in sentinel node procedures Br J Radiol 76 902 2003 117 122
78. T.L. Klausen, A.H. Chakera, and E. Friis Radiation doses to staff involved in sentinel node operations for breast cancer Clin Physiol Funct Imaging 25 4 2005 196 202
79. D. Nejc, M. Wrzesien, and J. Piekarski Sentinel node biopsy in patients with breast cancer - Evaluation of exposure to radiation of medical staff Eur J Surg Oncol 32 2 2006 133 138
80. E.C. Glass, and W.A. Waddington Radiation protection in radioguided surgery, Chapter 5 G. Mariani, A.E. Giuliano, H.W. Strauss, Radioguided Surgery: A Comprehensive Team Approach 2008 Springer Science+Business Media, LLC New York, NY 37 47
81. E.C. Glass, J.E. Basinski, and D.L. Krasne Radiation safety considerations for sentinel node techniques Ann Surg Oncol 6 1 1999 10 11
82. M. Singleton, M. Firth, and T. Stephenson Radiation-guided breast sentinel lymph node biopsies - Is a handling delay for radiation protection necessary? Histopathology 61 2 2012 277 282
83. Tc99m Sulphur Colloid [package insert] B, MA, Pharmalucence, Inc. 2012
84. A. Keleher, R. Wendt 3rd, and E. Delpassand The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid Breast J. 10 6 2004 492 495
85. P.M. Spanheimer, M.M. Graham, and S.L. Sugg Measurement of uterine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy Ann Surg Oncol 16 5 2009 1143 1147
86. NRC regulatory issue summary 2008-31. Licensing requirements for sentinel lymph node biopsy. USNR Commission, Office of Federal and State Materials and Environmental Management Programs, Washington, DC, USA, 2008
87. M.R.S. Keshtgar, W.A. Waddington, S.R. Lakhani, and P.J. Ell The sentinel node in surgical oncology. Chapter 8 M.R.S. Keshtgar, W.A. Waddington, S.R. Lakhani, P.J. Ell, Dosimetry and radiation protection. 1999 Springer London 92 101
88. M. Law, W.H. Ma, and R. Leung Evaluation of patient effective dose from sentinel lymph node lymphoscintigraphy in breast cancer: A phantom study with SPECT/CT and ICRP-103 recommendations Eur J Radiol 81 5 2012 e717 e720
89. U. Veronesi, P. Arnone, and P. Veronesi The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series Ann Oncol 19 9 2008 1553 1560
90. R.C. Chen, N.U. Lin, and M. Golshan Internal mammary nodes in breast cancer: Diagnosis and implications for patient management - A systematic review J Clin Oncol 26 30 2008 4981 4989
91. M.S. Yao, B.F. Kurland, and A.H. Smith Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer Ann Surg Oncol 14 10 2007 2985 2993
92. D.R. Byrd, L.K. Dunnwald, and D.A. Mankoff Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy Ann Surg Oncol 8 3 2001 234 240
93. V. Galimberti, P. Veronesi, and P. Arnone Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients Ann Surg Oncol 9 9 2002 924 928
94. C. Andree, V.J. Schmidt, and B.I. Munder Detecting of breast cancer metastasis by means of regional lymph node sampling during autologous breast reconstruction - A screening of 519 consecutive patients Med Sci Monit 18 10 2012 CR605 CR610
95. Q. He, D. Zhuang, and J. Tian Surgical approach to internal mammary sentinel node biopsy J Invest Surg 23 6 2010 321 326
96. S. van Esser, E.V. Madsen, and T. van Dalen Axillary staging in breast cancer patients with exclusive lymphoscintigraphic drainage to the internal mammary chain World J Surg 35 1 2011 159 164
97. G. Pechlivanides, D. Vassilaros, and A. Tsimpanis Sentinel node biopsy for breast cancer patients: Issues for discussion and our practice Pathol Res Int 2011 2010 109712
98. R. Camp, R. Feezor, and A. Kasraeian Sentinel lymph node biopsy for ductal carcinoma in situ: An evolving approach at the University of Florida Breast J. 11 6 2005 394 397
99. B. Cutuli, C.C. Le-Nir, and D. Serin Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases Crit Rev Oncol Hematol 73 3 2010 246 254
100. I.S. Fentiman, A. Fourquet, and G.N. Hortobagyi Male breast cancer Lancet. 367 9510 2006 595 604
101. O. Gentilini, E. Chagas, and S. Zurrida Sentinel lymph node biopsy in male patients with early breast cancer Oncologist 12 5 2007 512 515
102. E.I. Blumgart, R.F. Uren, and P.M. Nielsen Lymphatic drainage and tumour prevalence in the breast: A statistical analysis of symmetry, gender and node field independence J Anat 218 6 2011 652 659
103. H. Suami, W.R. Pan, and G.B. Mann The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy: A human cadaver study Ann Surg Oncol 15 3 2008 863 871
104. E. Kang, I.Y. Chung, and S.A. Han Feasibility of sentinel lymph node biopsy in breast cancer patients with initial axillary lymph node metastasis after primary systemic therapy J Breast Cancer 14 2 2011 147 152
105. B. Ansari, and J.C. Boughey Sentinel lymph node surgery in uncommon clinical circumstances Surg Oncol Clin N Am 19 3 2010 539 553
106. A.M. Kelly, B. Dwamena, and P. Cronin Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta analysis Acad Radiol 16 5 2009 551 563
107. C. van Deurzen, B. Vriens, and V. Tjan-Heijnen Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: A systematic review Eur J Cancer 45 18 2009 3124 3130
108. Y. Xing, M. Foy, and D. Cox Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer Br J Surg 93 5 2006 539 546
109. J.M. Classe, V. Bordes, and L. Campion Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: Results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study J Clin Oncol 27 5 2009 726 732
110. R.W. Carlson, D.C. Allred, and B.O. Anderson Breast cancer. Clinical practice guidelines in oncology J Natl Compr Canc Netw 7 2 2009 122 192
111. American Medical Association, CPT 2013 Professional Edition. IL, USA, American Medical Association Press, 2012